Compare INTT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTT | DRIO |
|---|---|---|
| Founded | 1981 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.9M | 84.1M |
| IPO Year | 1997 | N/A |
| Metric | INTT | DRIO |
|---|---|---|
| Price | $8.57 | $12.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $11.50 | ★ $50.00 |
| AVG Volume (30 Days) | ★ 38.9K | 23.5K |
| Earning Date | 03-06-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $117,606,000.00 | $24,732,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.60 | $20.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.29 |
| 52 Week Low | $5.24 | $5.94 |
| 52 Week High | $9.49 | $17.74 |
| Indicator | INTT | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 61.56 | 51.69 |
| Support Level | $7.69 | $11.75 |
| Resistance Level | $8.95 | $12.22 |
| Average True Range (ATR) | 0.42 | 0.90 |
| MACD | 0.11 | 0.09 |
| Stochastic Oscillator | 80.46 | 54.81 |
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.